{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:14:34Z","timestamp":1782962074004,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"am","delay-in-days":412,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jdermsci.2021.07.007","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T02:17:06Z","timestamp":1626920226000},"page":"109-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Serum lactate dehydrogenase level as a possible predictor of treatment preference in psoriasis"],"prefix":"10.1016","volume":"103","author":[{"given":"Hanako","family":"Koguchi-Yoshioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Ishitsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Okiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsuzaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Shimano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2021.07.007_bib0005","doi-asserted-by":"crossref","first-page":"594735","DOI":"10.3389\/fimmu.2020.594735","article-title":"The IL-23\/IL-17 pathway in inflammatory skin diseases: from bench to bedside","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jdermsci.2021.07.007_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/1346-8138.15913","article-title":"Pathophysiology of psoriasis: a review","author":"Yamanaka","year":"2021","journal-title":"J. Dermatol."},{"issue":"6","key":"10.1016\/j.jdermsci.2021.07.007_bib0015","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis","volume":"201","author":"Hawkes","year":"2018","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.jdermsci.2021.07.007_bib0020","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/jdv.14433","article-title":"The role of IL-23 and the IL-23\/T(H) 17 immune axis in the pathogenesis and treatment of psoriasis","volume":"31","author":"Girolomoni","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"3","key":"10.1016\/j.jdermsci.2021.07.007_bib0025","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/bjd.14947","article-title":"Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm(\u00ae) - and placebo-controlled trial (BRIDGE)","volume":"176","author":"Mrowietz","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"6387","key":"10.1016\/j.jdermsci.2021.07.007_bib0030","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1126\/science.aan4665","article-title":"Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity","volume":"360","author":"Kornberg","year":"2018","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.jdermsci.2021.07.007_bib0035","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1073\/pnas.83.14.5272","article-title":"Deficiency of cyclic AMP-dependent protein kinases in human psoriasis","volume":"83","author":"Brion","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8648","key":"10.1016\/j.jdermsci.2021.07.007_bib0040","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(89)92748-7","article-title":"A cAMP binding abnormality in psoriasis","volume":"1","author":"Raynaud","year":"1989","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jdermsci.2021.07.007_bib0045","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2133.1975.tb03140.x","article-title":"On the lack of response to catecholamine stimulation by the adenyl cyclase system in psoriatic lesions","volume":"92","author":"Yoshikawa","year":"1975","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.jdermsci.2021.07.007_bib0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2133.1975.tb06490.x","article-title":"Is the cyclic AMP in psoriatic epidermis low?","volume":"93","author":"Yoshikawa","year":"1975","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.jdermsci.2021.07.007_bib0055","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.cellsig.2010.11.018","article-title":"Cyclic AMP-mediated immune regulation--overview of mechanisms of action in T cells","volume":"23","author":"Mosenden","year":"2011","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.jdermsci.2021.07.007_bib0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cell.2012.01.017","article-title":"Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases","volume":"148","author":"Park","year":"2012","journal-title":"Cell"},{"issue":"9843","key":"10.1016\/j.jdermsci.2021.07.007_bib0065","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0140-6736(12)60642-4","article-title":"Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial","volume":"380","author":"Papp","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jdermsci.2021.07.007_bib0070","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/bjd.14164","article-title":"Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)","volume":"173","author":"Paul","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.jdermsci.2021.07.007_bib0075","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1111\/j.1468-3083.2012.04716.x","article-title":"Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study","volume":"27","author":"Papp","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.jdermsci.2021.07.007_bib0080","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jdv.14598","article-title":"Apremilast in psoriasis - a prospective real-world study","volume":"32","author":"Vujic","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.jdermsci.2021.07.007_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170975","article-title":"Advances in the quantification of mitochondrial function in primary human immune cells through extracellular flux analysis","volume":"12","author":"Nicholas","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jdermsci.2021.07.007_bib0090","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/bjd.12110","article-title":"Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study","volume":"168","author":"Papp","year":"2013","journal-title":"Br. J. Dermatol."},{"issue":"suppl 1","key":"10.1016\/j.jdermsci.2021.07.007_bib0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000501990","article-title":"Secukinumab for psoriasis in obese patients: minireview and clinical experience","volume":"11","author":"Tiberio","year":"2019","journal-title":"Case Rep. Dermatol."},{"issue":"6","key":"10.1016\/j.jdermsci.2021.07.007_bib0100","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1346-8138.1993.tb01296.x","article-title":"Significance of elevated serum squamous cell carcinoma (SCC)-related antigen and lactate dehydrogenase (LDH) levels in senile erythroderma following eczema","volume":"20","author":"Tsukahara","year":"1993","journal-title":"J. Dermatol."},{"issue":"8","key":"10.1016\/j.jdermsci.2021.07.007_bib0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1346-8138.1990.tb01679.x","article-title":"Significance of elevated serum LDH (lactate dehydrogenase) activity in atopic dermatitis","volume":"17","author":"Mukai","year":"1990","journal-title":"J. Dermatol."},{"issue":"2564","key":"10.1016\/j.jdermsci.2021.07.007_bib0110","article-title":"In vitro and in vivo effects of lactate on metabolism and cytokine production of human primary PBMCs and monocytes","volume":"9","author":"Ratter","year":"2018","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.jdermsci.2021.07.007_bib0115","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1158\/0008-5472.CAN-16-2938","article-title":"Deletion of lactate Dehydrogenase-A in myeloid cells triggers antitumor immunity","volume":"77","author":"Seth","year":"2017","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.jdermsci.2021.07.007_bib0120","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1073\/pnas.1920413117","article-title":"Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8+ T cell stemness and antitumor immunity","volume":"117","author":"Hermans","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6311","key":"10.1016\/j.jdermsci.2021.07.007_bib0125","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.aaf6284","article-title":"Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism","volume":"354","author":"Peng","year":"2016","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jdermsci.2021.07.007_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms t cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.jdermsci.2021.07.007_bib0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1042\/BSR20080002","article-title":"Stimulation of mitochondrial proton conductance by hydroxynonenal requires a high membrane potential","volume":"28","author":"Parker","year":"2008","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.jdermsci.2021.07.007_bib0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-3-319-55330-6_20","article-title":"Mitochondrial proton leak plays a critical role in pathogenesis of cardiovascular diseases","volume":"982","author":"Cheng","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jdermsci.2021.07.007_bib0145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1749-6632.1986.tb15528.x","article-title":"Regulation of lactate dehydrogenase gene expression by cAMP-dependent protein kinase subunits","volume":"478","author":"Jungmann","year":"1986","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.jdermsci.2021.07.007_bib0150","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00403-017-1748-x","article-title":"Serum fatty acid profile in psoriasis and its comorbidity","volume":"309","author":"My\u015bliwiec","year":"2017","journal-title":"Arch. Dermatol. Res."},{"issue":"3","key":"10.1016\/j.jdermsci.2021.07.007_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2019.07.004","article-title":"Fatty acid metabolites combine with reduced \u03b2 oxidation to activate Th17 inflammation in human type 2 diabetes","volume":"30","author":"Nicholas","year":"2019","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.jdermsci.2021.07.007_bib0160","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1189\/jlb.3AB0417-159RR","article-title":"Fatty acid synthase regulates the pathogenicity of Th17 cells","volume":"102","author":"Young","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jdermsci.2021.07.007_bib0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","article-title":"The biochemistry and physiology of mitochondrial fatty acid \u03b2-Oxidation and its genetic disorders","volume":"78","author":"Houten","year":"2016","journal-title":"Annu. Rev. Physiol."},{"issue":"1","key":"10.1016\/j.jdermsci.2021.07.007_bib0170","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/exd.13831","article-title":"Mitochondrial dysfunction in affected skin and increased mitochondrial DNA in serum from patients with psoriasis","volume":"28","author":"Therianou","year":"2019","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.07.007_bib0175","article-title":"Alterations of mitochondrial respiration and complex I activity in mononucleate cells from psoriatic patients: possible involvement of GRIM-19-STAT3\u03b1\/\u03b2","volume":"05","author":"Scrima","year":"2014","journal-title":"J. Clin. Cell. Immunol."},{"key":"10.1016\/j.jdermsci.2021.07.007_bib0180","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3389\/fimmu.2019.02285","article-title":"Targeting t cell metabolism in inflammatory skin disease","volume":"10","author":"von Meyenn","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jdermsci.2021.07.007_bib0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-065X.2012.01150.x","article-title":"Metabolic switching and fuel choice during T-cell differentiation and memory development","volume":"249","author":"van der Windt","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jdermsci.2021.07.007_bib0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-4598-11-76","article-title":"Importance of glycolysis and oxidative phosphorylation in advanced melanoma","volume":"11","author":"Ho","year":"2012","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.jdermsci.2021.07.007_bib0195","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060750","article-title":"Lactate dehydrogenases as metabolic links between tumor and stroma in the tumor microenvironment","volume":"11","author":"Mishra","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.jdermsci.2021.07.007_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.01.039","article-title":"Dynamic Imaging of LDH Inhibition in Tumors Reveals Rapid In Vivo Metabolic Rewiring and Vulnerability to Combination Therapy","volume":"30","author":"Oshima","year":"2020","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.jdermsci.2021.07.007_bib0205","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cmet.2018.03.008","article-title":"The science and translation of lactate shuttle theory","volume":"27","author":"Brooks","year":"2018","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.jdermsci.2021.07.007_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.01.022","article-title":"Mitochondrial oxidative phosphorylation regulates the fate decision between pathogenic Th17 and regulatory t cells","volume":"30","author":"Shin","year":"2020","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.jdermsci.2021.07.007_bib0215","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J. Invest. Dermatol."},{"issue":"7","key":"10.1016\/j.jdermsci.2021.07.007_bib0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181039","article-title":"An update on psoriasis and metabolic syndrome: a meta-analysis of observational studies","volume":"12","author":"Singh","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jdermsci.2021.07.007_bib0225","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study","volume":"157","author":"Gisondi","year":"2007","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.jdermsci.2021.07.007_bib0230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clindermatol.2017.09.005","article-title":"Psoriasis and the metabolic syndrome","volume":"36","author":"Gisondi","year":"2018","journal-title":"Clin. Dermatol."},{"issue":"1","key":"10.1016\/j.jdermsci.2021.07.007_bib0235","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1172\/JCI76012","article-title":"Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation","volume":"125","author":"Gerriets","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jdermsci.2021.07.007_bib0240","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1038\/s41467-019-13731-z","article-title":"IL-17(+) CD8(+) T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis","volume":"10","author":"L\u00fcckel","year":"2019","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.jdermsci.2021.07.007_bib0245","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/rheumatology\/kez204","article-title":"Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis","volume":"58","author":"Mavropoulos","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jdermsci.2021.07.007_bib0250","article-title":"CME part I psoriasis: which therapy for which patient psoriasis comorbidities and preferred systemic agents","author":"Kaushik","year":"2018","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181121001730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181121001730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:51:35Z","timestamp":1760331095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181121001730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0923181121001730"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2021.07.007","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum lactate dehydrogenase level as a possible predictor of treatment preference in psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2021.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}